Mary Butcher
Family Medicine · Columbus, OHNPI 1366540379
Payments from drug & device makers
Across 184 payments — averaging $15.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Azurity Pharmaceuticals, Inc.$753
- AbbVie$339
- Arbor Pharmaceuticals, Inc.$240
- AstraZeneca$226
- Kowa Pharmaceuticals America, Inc.$196
- Merck$181
- plus $900 from 15 others
What the payments were for
- Food & beverage$2,836100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Azurity Pharmaceuticals, Inc. | 42 | $753 |
| AbbVie | 28 | $339 |
| Arbor Pharmaceuticals, Inc. | 17 | $240 |
| AstraZeneca | 14 | $226 |
| Kowa Pharmaceuticals America, Inc. | 15 | $196 |
| Merck | 11 | $181 |
| IBSA Pharma Inc. | 11 | $175 |
| Lilly USA, LLC | 6 | $103 |
| Novo Nordisk | 7 | $96 |
| Paratek Pharmaceuticals, Inc. | 5 | $93 |
| Exact Sciences | 5 | $84 |
| Bayer | 4 | $69 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $53 |
| Pfizer | 3 | $46 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Amneal Pharmaceuticals LLC | 2 | $29 |
| Antares Pharma, Inc. | 1 | $28 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $25 |
| Biohaven Pharmaceuticals, Inc. | 2 | $23 |
| Astellas Pharma US Inc | 1 | $18 |
| Currax Pharmaceuticals LLC | 2 | $16 |
How this compares
$2,836 in reported general payments places this provider in the 75th percentile of 3,983 family medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 46 | $50,876 |
| OzempicSemaglutide | 50 | $46,785 |
| JanuviaSitagliptin Phosphate | 16 | $25,983 |
| XareltoRivaroxaban | 17 | $17,029 |
| SynthroidLevothyroxine Sodium | 81 | $7,648 |
| JanumetSitagliptin Phos/Metformin Hcl | 12 | $7,500 |
| Nebivolol Hcl | 36 | $3,590 |
| Rosuvastatin Calcium | 222 | $2,357 |
| Atorvastatin Calcium | 104 | $896 |
| Telmisartan | 28 | $781 |
| Bupropion XlBupropion Hcl | 31 | $764 |
| Levothyroxine Sodium | 110 | $748 |
| Telmisartan-HydrochlorothiazidTelmisartan/Hydrochlorothiazid | 17 | $587 |
| Amlodipine Besylate | 90 | $484 |
| ValacyclovirValacyclovir Hcl | 17 | $447 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $226 | $50,87646 claims |
| Novo NordiskOzempic | $96 | $46,78550 claims |
| MerckJanuvia, Janumet | $181 | $33,48328 claims |
| AbbVieSynthroid | $339 | $7,64881 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $29 | $748110 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Columbus
- Cathy GreiweColumbus$1.4M
- Brian BeesleyColumbus$1.4M
- Robert FloreaColumbus$955K
- Bryan FeldmanColumbus$404K
- Scott MerrymanColumbus$89K
- Michael ButcherCincinnati$18.3M
- William RandallKettering$7.5M
- Paul NugentCincinnati$4.9M
- Steve ChoiDayton$4.8M
- Martin SchearDayton$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.